Sequential Gemcitabine+Docetaxel an Effective Alternative to BCG in High-Risk NMIBC

Investigators compared the benefits of gemcitabine and docetaxel vs Bacillus Calmette-Guérin (BCG) in nonmuscle invasive bladder cancer (NMIBC).

Related Keywords

Vignesht Packiam , ,University Of Iowa ,University Of Iowa Hospitals ,Iowa Hospitals ,Iowa City ,